Product Information

BROMFENAC SODIUM 0.07% EYE DRP is a generic product labeled by Apotex Corp., priced at $12.6625 per ML under NDC 60505100602. Its NADAC has been published 105 times since Aug 21, 2024.

FDA first approved this application on Jul 8, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BROMFENAC SODIUM 0.07% EYE DRP

Bromfenac Sodium
$12.6625per ML

Strength

.7 mg/mL

Manufacturer

Apotex Corp.

NDC

60505100602

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA207334

FDA Approved

7/8/2024

TE Code

AB

On Market Since

7/11/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.07% EYE DRP has been published 105 times since Aug 21, 2024, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.

Current price$12.6625 per ML
All-time high$68.2970 (Sep 11, 2024)
All-time low$11.7673 (Apr 22, 2026)
52-week high$15.4792
52-week low$11.7673
Median price$15.1836
Average price$19.1087
Largest weekly change-53.9% (Nov 20, 2024)
Weeks tracked105
Tracking sinceAug 21, 2024

Price History

1W

-2.7%

1M

-2.7%

3M

-1.5%

6M

-5.3%

1Y

-18.2%

3Y

N/A

5Y

N/A

All

-81.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.07% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.07% EYE DRP, manufactured by Apotex Corp., is $12.6625 per ML (NDC 60505100602), effective Aug 19, 2026.

How has the price of BROMFENAC SODIUM 0.07% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has declined 81.5%. It has been tracked across 105 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.07% EYE DRP?

Since Aug 21, 2024, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has ranged from a low of $11.7673 (Apr 22, 2026) to a high of $68.2970 (Sep 11, 2024), with a median of $15.1836 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.07% EYE DRP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BROMFENAC SODIUM 0.07% EYE DRP in a comparable dosage form, but none are currently priced below it.

Who manufactures BROMFENAC SODIUM 0.07% EYE DRP?

BROMFENAC SODIUM 0.07% EYE DRP (NDC 60505100602) is labeled by Apotex Corp., and CMS classifies it as a generic product.